Ptc Therapeutics (PTCT) Inventory Average (2017 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Inventory Average of $83.5 million for Q2 2026, up 199.49% year-over-year from $27.9 million in Q2 2025, and up 7.54% quarter-over-quarter from $77.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Inventory Average (2017 - 2026) Analysis & Trends
Ptc Therapeutics' Inventory Average history runs 10 years deep, the most recent figure standing at $83.5 million for Q2 2026.
- In Q2 2026, Inventory Average rose 199.49% year-over-year to $83.5 million; the TTM figure through Jun 2026 stood at $83.5 million (up 199.49% YoY), while the FY2025 annual figure was $51.4 million, up 91.26% from the prior year.
- Inventory Average for Q2 2026 stood at $83.5 million, up from $77.6 million in the prior quarter.
- The five-year high for Inventory Average was $83.5 million in Q2 2026, with the low at $14.9 million in Q3 2022.
- The 5-year median for Inventory Average is $29.9 million (2024), against an average of $35.0 million.
- The sharpest annual moves came in 2025 and 2026: Inventory Average fell 26.0% in 2025, then surged 245.93% in 2026.
- Ptc Therapeutics' Inventory Average stood at $18.3 million in 2022, then jumped by 81.13% to $33.2 million in 2023, then fell by 11.25% to $29.4 million in 2024, then jumped by 124.81% to $66.2 million in 2025, then rose by 26.14% to $83.5 million in 2026.
- Business Quant data shows PTCT's Inventory Average at $83.5 million in Q2 2026, $77.6 million in Q1 2026, and $66.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 83.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.46 Mn |
| Mar 31, 2026 | 77.61 Mn |
| Dec 31, 2025 | 66.17 Mn |
| Sep 30, 2025 | 43.37 Mn |
| Jun 30, 2025 | 27.87 Mn |
| Mar 31, 2025 | 22.43 Mn |
| Dec 31, 2024 | 29.43 Mn |
| Sep 30, 2024 | 33.75 Mn |
| Jun 30, 2024 | 30.94 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 33.16 Mn |
| Sep 30, 2023 | 33.89 Mn |
| Jun 30, 2023 | 29.33 Mn |
| Mar 31, 2023 | 24.23 Mn |
| Dec 31, 2022 | 18.31 Mn |
| Sep 30, 2022 | 14.91 Mn |
| Jun 30, 2022 | 15.14 Mn |
| Mar 31, 2022 | 15.57 Mn |
| Dec 31, 2021 | 15.73 Mn |
| Sep 30, 2021 | 16.03 Mn |